Non-alcoholic fatty liver disease risk factors: Difference between revisions
Aditya Ganti (talk | contribs) |
|||
(8 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of NAFLD is obesity. Other risk factors include insulin | The most potent risk factor in the development of NAFLD is [[obesity]]. Other risk factors include [[insulin resistance]] and [[metabolic syndrome]]. | ||
==Risk Factors== | ==Risk Factors== | ||
Risk factors in the development of non-alcoholic fatty liver disease include:<ref name="pmid25892859">{{cite journal| author=Streba LA, Vere CC, Rogoveanu I, Streba CT| title=Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. | journal=World J Gastroenterol | year= 2015 | volume= 21 | issue= 14 | pages= 4103-10 | pmid=25892859 | doi=10.3748/wjg.v21.i14.4103 | pmc=4394070 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25892859 }} </ref><ref name="pmid22319959">{{cite journal| author=He S, Bao W, Shao M, Wang W, Wang C, Sun J et al.| title=Risk factors for non-alcoholic fatty liver disease in a Chinese population. | journal=Acta Gastroenterol Belg | year= 2011 | volume= 74 | issue= 4 | pages= 503-8 | pmid=22319959 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22319959 }} </ref><ref name="pmid258928592">{{cite journal |vauthors=Streba LA, Vere CC, Rogoveanu I, Streba CT |title=Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question |journal=World J. Gastroenterol. |volume=21 |issue=14 |pages=4103–10 |year=2015 |pmid=25892859 |pmc=4394070 |doi=10.3748/wjg.v21.i14.4103 |url=}}</ref> | |||
*[[Viral hepatitis]] | |||
* | *Rapid [[weight loss]] | ||
*[[Malnutrition]] | |||
* | *[[Hypertriglyceridemia]] | ||
* | *[[Sleep apnea]] | ||
* | *[[Hypothyroidism]] | ||
* | *[[Obesity]] | ||
* | *[[Hypopituitarism]] | ||
* | *[[Diabetes mellitus type 2]] | ||
*[[Polycystic ovary syndrome|PCOS]] ([[polycystic ovarian syndrome]]) | |||
*Medications like [[tamoxifen]], [[corticosteriods]], [[methotrexate]] | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 15:07, 27 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease risk factors On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease risk factors |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Risk calculators and risk factors for Non-alcoholic fatty liver disease risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The most potent risk factor in the development of NAFLD is obesity. Other risk factors include insulin resistance and metabolic syndrome.
Risk Factors
Risk factors in the development of non-alcoholic fatty liver disease include:[1][2][3]
- Viral hepatitis
- Rapid weight loss
- Malnutrition
- Hypertriglyceridemia
- Sleep apnea
- Hypothyroidism
- Obesity
- Hypopituitarism
- Diabetes mellitus type 2
- PCOS (polycystic ovarian syndrome)
- Medications like tamoxifen, corticosteriods, methotrexate
References
- ↑ Streba LA, Vere CC, Rogoveanu I, Streba CT (2015). "Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question". World J Gastroenterol. 21 (14): 4103–10. doi:10.3748/wjg.v21.i14.4103. PMC 4394070. PMID 25892859.
- ↑ He S, Bao W, Shao M, Wang W, Wang C, Sun J; et al. (2011). "Risk factors for non-alcoholic fatty liver disease in a Chinese population". Acta Gastroenterol Belg. 74 (4): 503–8. PMID 22319959.
- ↑ Streba LA, Vere CC, Rogoveanu I, Streba CT (2015). "Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question". World J. Gastroenterol. 21 (14): 4103–10. doi:10.3748/wjg.v21.i14.4103. PMC 4394070. PMID 25892859.